ABUS Banner

Invenia ABUS 2.0

Look differently at dense breast tissue

ABUS Banner

Invenia ABUS 2.0

Look differently at dense breast tissue

Use remarkable image quality, the coronal view, and advanced interpretation tools to look differently at dense breast tissue for adjunctive screening and diagnostic exams.

 
Evidence shows mammography ultrasounds aren't always reliable

Invenia ABUS 2.0 can improve early detection

Clinical impact

Discover real-world outcomes and its clinical impact -- from the effectiveness of breast screening to improved cancer detection and economic outcomes.

Read the SomoInsight Study to learn about the effectiveness of ABUS for supplemental breast screening.

Download the study

Cancer detection improves for women with dense breasts when Automated Breast Ultrasound screening is combined with 3D tomosynthesis.

Learn more

Mammography plus Automated Breast Ultrasound (ABUS) results can improve earlier detection of breast cancer.

Learn more

Automated Breast Ultrasound clarifies diagnosis of subareolar mass in dense breast.

Learn more

Surgeon use of 3D Automated Breast Ultrasound (ABUS): The dense breast screening tool and its potential role for preoperative staging.

Learn more

 

Economic impact

Commercial reimbursement and utilization for Invenia ABUS (Automated Breast Ultrasound).

Learn more

Real World Experience and Outcomes with Invenia ABUS (Automated Breast Ultrasound) Imaging For Women.

Learn More

Webinars

These complimentary webinars feature experienced ABUS users who discuss ABUS in clinical practice.

Developing a personalized breast screening program

Dr. Joseph Russo, Section Chief of Women's Imaging, St. Luke's University Health Network, Bethlehem, PA

Learn More
Dense breast tissue: Status of ultrasound for breast cancer screening

Marc F Inciardi, MD, Assistant Professor of Radiology, Section Head, Breast Imaging, University of Kansas Medical Center

Learn More
Implementation of ABUS in the community setting

Monica H Saini MD, MS, Breast Radiologist

Learn More
Screening ultrasound

Ian Grady MD, FACS, North Valley Breast Center, Redding, CA

Learn More
Automated breast sonographic coronal imaging: Diagnostic and screening applications

Beverly E Hashimoto, MD, FACR, Section Head, Ultrasound, Virginia Mason Medical Center, Seattle, WA

Learn More
Introduction to Automated Breast Ultrasound Screening women with dense breasts

Dr. Monica Saini, MD, CMO for Institute of Women’s Imaging and Medical Director for ABUS at GE Healthcare

Learn More
Case review and clinical discussion of the clinical effectiveness of 3D ABUS at ECR 2018

Athina D. Vourtsis MD, PhD, Director and Founder of Diagnostic Mammography Center, Athens, Greece

Learn More
Breast anatomy, 2D, 3D, and Automated Breast Ultrasound

Mary Henne, MS, CNMT, RDMS, RVT, Clinical Research Education Leader - ABUS and Beverly E Hashimoto, M.D., FACR, Section Head, Ultrasound, Virginia Mason Medical Center, Seattle, WA

Learn More
 
Testimonials

What are clinicians and patients saying about their experience with ABUS?

From clinicians to patients, ABUS users discuss the clinical need for supplemental screening for dense breasts and how ABUS has performed in clinical practice. Patients and clinicians alike provide their impressions of ABUS supplemental screening for dense breasts and how it has benefited them. For more information on breast care for patients, please visit knowyourrisk.gehealthcare.com

Education

Mastery Program for Physicians and Technologists is led by experienced and certified peer educators to help rapidly build confidence to read Invenia ABUS 2.0 images. Technologist training occurs on-site for your convenience and offers up to 8 CME credits for participants.

For more information download the Invenia ABUS 2.0 Education Information Sheet.

Download Sheet

Resources

Marketing

Our dedicated support team is available to help you implement your ABUS program and make it a success. Users receive guidance and best practices, including real-world samples and professionally designed templates. Users also receive recommendations for educating key audiences, workflow options and marketing strategies help you launch your ABUS program.

Learn more about marketing tools and the ABUS Club

Invenia ABUS 2.0 system consumable supplies

GE Healthcare offers an array of consumable supplies for the Invenia™ ABUS 2.0 and somo•v™ ABUS (Automated Breast Ultrasound) Platinum systems including scan membranes, Polysonic® ultrasound lotions, and Protex™ disinfectants. For a complete list of ABUS 2.0 accessories, visit: www.services.gehealthcare.com

Services

GE Healthcare's AssurePoint Service offering helps enhance the overall total value of ownership of your Invenia ABUS 2.0.

Download a service information sheet

Educating Patients

Early detection of breast cancer enables treatment to be started earlier in the course of the disease, possibly before it has spread. Encourage your patients with dense breasts to advocate for their health and learn more about ABUS. Use the GE Healthcare ABUS Locator tool to find a facility in their area, and direct them to the website, pamphlet and video below.

Find an ABUS scanning facility in your area

Know Your Risk website

Patient education video

Patient pamphlet

Reimbursement

GE Healthcare is pleased to offer providers coding and reimbursement support:

Toll-free phone number: 1-844-386-0099
Email: GEABUS@emersonconsultants.com
Visit our reimbursement website

GE Healthcare agrees to abide by the provisions of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and any other relevant state or federal privacy laws and regulations concerning the use and/or disclosure of protected health information during the course of providing this support. CPT CODES are copyrighted by the American Medical Association.

1. Mandelson et al. J Natl Cancer Inst 2000; 92:1081–1087.
2. Tagliafico, Massimo Calabrese et al, Journal of Clinical Oncology 2016 34:16, 1882-1888.
3. Brem et al, Radiology, March 2015.
4. Pisano et al. NEJM 2005; 353: 1773.
5. Engmann NJ, et al, JAMA Oncol. 2017;3(9):1228-1236
6. Boyd NF et al. Mammographic Density and the Risk and Detection of Breast Cancer. NEJM 2007; 356: 227-36.
7. Arora N, King TA, Jacks LM., Ann Surg Onc, 2010; 17:S211-18.